Eltham, Australia

Mark Darren Hulett

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Balmoral Australia Pty Ltd, Hexima Limited. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mark Darren Hulett. Retrieved from https://idiyas.com/inventor/mark-darren-hulett

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mark Darren Hulett: Innovator in Plant Defensins and Proliferative Disease Treatment.

Introduction: Mark Darren Hulett is an accomplished inventor based in Eltham, Australia. He has made significant contributions to the field of biotechnology, particularly in the development of treatments for proliferative diseases. His innovative work focuses on utilizing plant-derived compounds to combat serious health issues.

Latest Patents: Hulett holds a patent for "Plant defensins and use in the treatment of proliferative diseases." This invention relates to compositions and methods aimed at preventing or treating proliferative diseases, including cancer. The patent emphasizes the use of plant defensins, which are proteins derived from plants, in therapeutic applications.

Career Highlights: Throughout his career, Hulett has worked with notable companies such as Balmoral Australia Pty Ltd and Hexima Limited. His experience in these organizations has allowed him to advance his research and contribute to the development of innovative solutions in the medical field.

Collaborations: Hulett has collaborated with various professionals in his field, including his coworker Fung Tso Lay. These partnerships have facilitated the exchange of ideas and fostered advancements in research related to plant defensins and their applications.

Conclusion: Mark Darren Hulett's work exemplifies the intersection of nature and medicine, showcasing the potential of plant-derived compounds in treating proliferative diseases. His contributions continue to inspire further research and innovation in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…